Institutional members access full text with Ovid®

Share this article on:

The Use of Left Ventricular Assist Devices in End-Stage Heart Failure

Blair, Ashley, BSN, RN

doi: 10.1097/CNQ.0000000000000223
Original Articles

Heart failure is one of the most common diagnoses in patients requiring multiple hospitalizations. The use of mechanical circulatory support (both temporary and durable), especially left ventricular assist devices (LVADs), in this patient population has evolved over the last decade. There are thousands of durable LVADs implanted in the United States annually as bridge to transplantation, destination therapy, or bridge to recovery. LVAD therapy, just like cardiac transplantation, takes a multidisciplinary team approach to achieve success. Appropriate patient selection is the key to good clinical outcomes. As the technology of LVAD therapy continues to evolve, it will be made available to an increasing number of patients in an attempt to improve their morbidity and mortality.

Allegheny Health Network, Allegheny General Hospital, Pittsburgh, Pennsylvania.

Correspondence: Ashley Blair, BSN, RN, Allegheny Health Network, Allegheny General Hospital, 320 East North Ave, Pittsburgh, PA 15212 (ashley.blair@ahn.org).

The author has disclosed that she has no significant relationships with, or financial interest in, any commercial companies pertaining to this article.

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved